Franciscus Gasthuis
Clinical trials sponsored by Franciscus Gasthuis, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Hidden heart risk in obesity: can early screening save lives? Results expected Dec 2026 (estimated)
-
Could a biologic drug free severe asthma patients from High-Dose steroids?
Disease control By invitation onlyThis study looks at whether people with severe asthma who start taking tezepelumab can safely lower their dose of inhaled corticosteroids. Researchers will track steroid use, asthma control, and flare-ups over 12 months in a real-world setting. The goal is to see if tezepelumab c…
Sponsor: Franciscus Gasthuis • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
Hidden heart risk in obesity: can early screening save lives?
Diagnosis OngoingThis trial tests whether actively screening adults with obesity for early signs of heart failure can improve their health outcomes. Adults aged 45 and older with a BMI of 30 or higher, who have no known heart disease, will be randomly assigned to receive either standard care or a…
Sponsor: Franciscus Gasthuis • Aim: Diagnosis
Last updated Sep 05, 2026 00:00 UTC